Lilly's GIP/GLP-1 agonist Mounjaro (tirzepatide) also outperformed Ozempic, and the formulation of the drug for obesity, ...

Eli Lilly’s blockbuster drug Mounjaro has quickly become the market leader in the segment, thanks to its strong clinical ...

“Imagine the shape of an hourglass,” says Ty Wiggins, who coaches new CEOs. “Chief executives sit at the pinch point. It’s a ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

Clonal hematopoiesis of indeterminate potential was not associated with an increased risk for heart disease but was linked to ...

While he has resigned, rather than being sacked, Ali has agreed to leave his post without being entitled to any severance ...